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Abstract (word limit: 250)
Background   Impaired autoregulation may contribute to the pathogenesis of cerebral small vessel disease (SVD). Reliable protocols for measuring microvascular reactivity are required to test this hypothesis and for providing secondary endpoints in clinical trials.
Aims   To develop and assess a protocol for acquisition and processing of cerebrovascular reactivity (CVR) by MRI, in subcortical tissue of patients with SVD and minor stroke.
Methods   We recruited 15 healthy volunteers, testing paradigms using 1- and 3-minute 6% CO2 challenges with repeat scanning, and 15 patients with history of minor stroke. We developed a protocol to measure CVR and delay times, assessing tolerability and reproducibility in grey and white matter (GM, WM) areas.
Results   The 3-minute paradigm yielded more reproducible data than the 1-minute paradigm (CV respectively: 7.9–15.4% and 11.7–70.2% for CVR in GM), and was less reproducible in WM (16.1–24.4% and 27.5–141.0%). Tolerability was similar for the two paradigms, but mean CVR and CVR delay were significantly higher for the 3-minute paradigm in most regions. Patient tolerability was high with no evidence of greater failure rate (1/15 patients vs. 2/15 volunteers withdrew at the first visit). GM CVR was lower in patients than in volunteers (0.110—0.234 vs. 0.172—0.313 %/mmHg; p<0.05 in 6/8 regions), as was the WM CVR delay (16.2—43.9 vs. 31.1—47.9 s; p<0.05 in 4/8 regions).





Cerebral small vessel disease (SVD) accounts for 20-25% of strokes and increases the risk of cognitive impairment, disability and dementia. The pathogenesis is poorly understood but there is evidence of a role for increased vessel stiffness; ADDIN EN.CITE ,  it is hypothesised that affected arterioles do not vasodilate efficiently in response to demand for increased blood flow, leading to secondary ischaemic damage. ADDIN EN.CITE 3 Impaired cerebrovascular reactivity has been reported in Alzheimer’s dementia ADDIN EN.CITE 4 and cerebral amyloid angiopathy. ADDIN EN.CITE 5 As a result there is growing interest in endothelial dysfunction as a therapeutic target for treating SVD and clinical trials of licenced drugs with relevant modes of action (e.g. Cilostazol and isosorbide mononitrate; https://clinicaltrials.gov/ct2/show/NCT02481323) and antihypertensive drugs have recently commenced at our centre and elsewhere.
Clinically feasible and reliable non-invasive methods for assessing microvessel reactivity would provide mechanistic insight and secondary endpoints in trials of drugs to prevent and reverse SVD. Transcranial Doppler ultrasound combined with a hypercapnic or pharmacologic challenge is well-established, and has been used to show reduced CVR in age-matched subjects with white matter hyperintensities (WMH) and similar vascular risk factors, ADDIN EN.CITE 6 but only provides information on blood flow in a chosen large artery. In contrast, MRI permits cerebrovascular reactivity (CVR) measurement throughout the brain using blood oxygenation level dependent (BOLD) imaging or arterial spin labelling (ASL) in response to a respiratory challenge. However, although CVR MRI has been widely used to study large artery diseases such as Moyamoya and carotid stenosis, ADDIN EN.CITE ,  the technique has infrequently been applied in the study of SVD. ADDIN EN.CITE 9-14 Although the aims, methods and findings of these studies were varied, Uh et al. reported a reduction in CVR both in WMH compared with normal-appearing WM (NAWM) and in the NAWM of subjects with greater WMH burden. ADDIN EN.CITE 14 This suggests a potentially valuable role for CVR measurement as a secondary endpoint in clinical trials of drugs for SVD prevention and reversal.





We recruited healthy volunteers, who were asked to attend two CVR scanning sessions, and patients with a past history of minor stroke, who were invited to a single scanning session. The study was conducted following Research Ethics Committee approvals (ref. 14/HV/0001 and 14/EM/1126) and according to the principles expressed in the Declaration of Helsinki. All subjects gave written informed consent.
Healthy volunteers were recruited from the surrounding area, excluding any potential participants having cardiovascular or respiratory illness, hypertension, migraine, anxiety disorders and panic attacks; we also excluded those with a known family history of intracranial aneurysm, subarachnoid haemorrhage, arteriovenous malformation as well as those with contraindications to MRI.
Patients were recruited from the in- and out-patient stroke service as described previously. ADDIN EN.CITE ,  We recruited patients presenting with a new clinical diagnosis of minor ischaemic stroke, i.e. that was non-disabling, and also from our register of patients with a clinical diagnosis of minor non-disabling ischaemic stroke in the past five years. ‘Non-disabling’ was defined as not requiring assistance in activities of daily living. We included those with diabetes, hypertension and other vascular risk factors as long as these were well controlled. We excluded patients with unstable hypertension, unstable diabetes, other neurological disorders, significant cardiac or respiratory illness or other life threatening medical conditions. We also excluded patients unable to give consent, with contraindications to MRI, and who had haemorrhagic stroke (but not haemorrhagic transformation of an infarct).  




During CVR MRI, subjects wore a unidirectional breathing circuit (Figure 1) designed by the University of Aberdeen and Intersurgical (Wokingham, UK; product code: 2013018) that enabled administration of air or a gas mixture containing 4 or 6% carbon dioxide; the circuit was open to room air via a length of anaesthetic breathing circuit (with a volume greater than tidal volume (350ml)) that served as a gas reservoir and ensured participant safety when the cylinder gas flow rate was insufficient or turned off. To ensure that accurate concentrations of CO2 were administered, two cylinders of certified, medical grade gas mixtures were used, containing 6% CO2, 21 % O2, 73% N2 and 4% CO2, 21 % O2, 75% N2 respectively (BOC Special Products, UK). The CO2 gas mixture was administered to volunteers using both a “1-minute” (four 1-minute blocks of air alternated with three 1-minute blocks of CO2) HYPERLINK \l "_ENREF_19" \o "Yezhuvath, 2009 #14"  ADDIN EN.CITE <EndNote><Cite><Author>Yezhuvath</Author><Year>2009</Year><RecNum>14</RecNum><DisplayText><style face="superscript">19</style></DisplayText><record><rec-number>14</rec-number><foreign-keys><key app="EN" db-id="v5sravvfipvw9tetrwo5xexpfdedvsdsvwtr" timestamp="1463497661">14</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Yezhuvath, U. S.</author><author>Lewis-Amezcua, K.</author><author>Varghese, R.</author><author>Xiao, G.</author><author>Lu, H.</author></authors></contributors><auth-address>Advanced Imaging Research Center, University of Texas Southwestern Medical Center, Dallas, 75390, USA.</auth-address><titles><title>On the assessment of cerebrovascular reactivity using hypercapnia BOLD MRI</title><secondary-title>NMR Biomed</secondary-title><alt-title>NMR in biomedicine</alt-title></titles><periodical><full-title>NMR Biomed</full-title><abbr-1>NMR in biomedicine</abbr-1></periodical><alt-periodical><full-title>NMR Biomed</full-title><abbr-1>NMR in biomedicine</abbr-1></alt-periodical><pages>779-86</pages><volume>22</volume><number>7</number><keywords><keyword>Adult</keyword><keyword>Brain Mapping</keyword><keyword>Carbon Dioxide/administration &amp; dosage</keyword><keyword>Cerebrovascular Circulation/*physiology</keyword><keyword>Female</keyword><keyword>Humans</keyword><keyword>Hypercapnia/*blood/*physiopathology</keyword><keyword>Magnetic Resonance Imaging/*methods</keyword><keyword>Male</keyword><keyword>Middle Aged</keyword><keyword>Oxygen/*blood</keyword><keyword>Respiration</keyword><keyword>Time Factors</keyword><keyword>Young Adult</keyword></keywords><dates><year>2009</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>1099-1492 (Electronic)&#xD;0952-3480 (Linking)</isbn><accession-num>19388006</accession-num><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/19388006</url></related-urls></urls><custom2>2726998</custom2><electronic-resource-num>10.1002/nbm.1392</electronic-resource-num></record></Cite></EndNote>19 and a “3-minute” (three 2-minute blocks of air interleaved with two 3-minute blocks of CO2) ADDIN EN.CITE 20 paradigm; as the results showed improved reproducibility with the latter, the 3-minute paradigm alone was used for patient CVR scans. We measured vital signs (peripheral oxygen saturation, blood pressure, heart rate, end-tidal CO2 (ETCO2) and respiratory rate) using a CD-3A CO2 sensor (AEI Technologies, Pittsburgh, USA) and MR patient monitors (Millennia 3155A and Magnitude 3150 MRI; Invivo, Best, The Netherlands). Gas cylinders and CO2 sensors were positioned in the MR control room; tubes and sample lines entered the scanner room via a waveguide.
Magnetic resonance imaging was acquired with a 1.5 Tesla MRI scanner (Signa HDxt, General Electric, Milwaukee, WI) using an 8-channel phased-array head coil. BOLD images were acquired every 3 seconds during the CVR scan using axial single-shot gradient echo echo-planar imaging (GE-EPI; TR/TE=3000/45 ms, 90° flip angle, 25.6 x 25.6 cm field of view (FoV), 64 x 64 acquisition matrix, 36 x 4 mm contiguous slices), including 8 dummy scans prior to the start of the gas paradigm.
For minor stroke patients, axial T2-weighted (T2W; TR/TE=7000/90 ms, 24 x 24 cm FoV, Propeller acquisition with matrix size 384, 1.5 signal averages, 36 x 4 mm contiguous slices), axial fluid-attenuated inversion recovery (FLAIR; TR/TE/TI=8000/100/2000, 24 x 24 cm FoV, 320 × 256 acquisition matrix, 36 x 4 mm contiguous slices), gradient echo (GRE; TR/TE=900/15 ms, 20° flip angle, 24 x 24 cm FoV, 384 × 256 acquisition matrix, 36 x 4 mm contiguous slices) and 3D T1-weighted imaging (T1W; inversion recovery-prepared spoiled gradient echo (SPGR), sagittal acquisition, TR/TE/TI=9.6/4.0/500 ms, 8° flip angle, 25.6 x 25.6 cm FoV, 192 × 192 acquisition matrix, 160 x 1.3 mm slices). For healthy volunteers, T2W and T1W structural images only were obtained using similar parameters.
Participants were asked to rate the tolerability of the CVR procedure on a four-point scale (“intolerable”, “not very tolerable”, “tolerable” or “very tolerable”) and healthy volunteers were asked which of the two paradigms was more tolerable.
Image Processing and Analysis
End-tidal CO2: ETCO2 values were obtained using the Millenia monitor with 1 s temporal resolution and stored digitally. For patients and a subset of the volunteers, CO2 waveforms generated by the CD-3A sensor were recorded digitally with a sampling rate of 20.s-1; these were converted to ETCO2 profiles using in-house Matlab code for identifying peaks in CO2 concentration corresponding to end-tidal values (MathWorks, Inc., MA, USA), which were temporally aligned with the Millenia ETCO2 profile. The CD-3A sensor was calibrated prior to each scan using room air and the certified gas mixtures, and readings from this device were used for determining CVR in patients; since most of the volunteers were measured using the Millenia monitor, ETCO2 readings were calibrated against the CD-3A device in a subset of volunteers so that data for patients and volunteers could be compared.
Cerebrovascular reactivity: A range of parameters and quantification methods have been proposed for CVR measurement, including linear regression with ADDIN EN.CITE 21 and without HYPERLINK \l "_ENREF_19" \o "Yezhuvath, 2009 #14"  ADDIN EN.CITE <EndNote><Cite><Author>Yezhuvath</Author><Year>2009</Year><RecNum>14</RecNum><DisplayText><style face="superscript">19</style></DisplayText><record><rec-number>14</rec-number><foreign-keys><key app="EN" db-id="v5sravvfipvw9tetrwo5xexpfdedvsdsvwtr" timestamp="1463497661">14</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Yezhuvath, U. S.</author><author>Lewis-Amezcua, K.</author><author>Varghese, R.</author><author>Xiao, G.</author><author>Lu, H.</author></authors></contributors><auth-address>Advanced Imaging Research Center, University of Texas Southwestern Medical Center, Dallas, 75390, USA.</auth-address><titles><title>On the assessment of cerebrovascular reactivity using hypercapnia BOLD MRI</title><secondary-title>NMR Biomed</secondary-title><alt-title>NMR in biomedicine</alt-title></titles><periodical><full-title>NMR Biomed</full-title><abbr-1>NMR in biomedicine</abbr-1></periodical><alt-periodical><full-title>NMR Biomed</full-title><abbr-1>NMR in biomedicine</abbr-1></alt-periodical><pages>779-86</pages><volume>22</volume><number>7</number><keywords><keyword>Adult</keyword><keyword>Brain Mapping</keyword><keyword>Carbon Dioxide/administration &amp; dosage</keyword><keyword>Cerebrovascular Circulation/*physiology</keyword><keyword>Female</keyword><keyword>Humans</keyword><keyword>Hypercapnia/*blood/*physiopathology</keyword><keyword>Magnetic Resonance Imaging/*methods</keyword><keyword>Male</keyword><keyword>Middle Aged</keyword><keyword>Oxygen/*blood</keyword><keyword>Respiration</keyword><keyword>Time Factors</keyword><keyword>Young Adult</keyword></keywords><dates><year>2009</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>1099-1492 (Electronic)&#xD;0952-3480 (Linking)</isbn><accession-num>19388006</accession-num><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/19388006</url></related-urls></urls><custom2>2726998</custom2><electronic-resource-num>10.1002/nbm.1392</electronic-resource-num></record></Cite></EndNote>19 a tissue-dependent delay, parameterisation of the ETCO2-BOLD response curve ADDIN EN.CITE 22, frequency-domain analysis, HYPERLINK \l "_ENREF_23" \o "Blockley, 2011 #19"  ADDIN EN.CITE <EndNote><Cite><Author>Blockley</Author><Year>2011</Year><RecNum>19</RecNum><DisplayText><style face="superscript">23</style></DisplayText><record><rec-number>19</rec-number><foreign-keys><key app="EN" db-id="v5sravvfipvw9tetrwo5xexpfdedvsdsvwtr" timestamp="1463500022">19</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Blockley, N. P.</author><author>Driver, I. D.</author><author>Francis, S. T.</author><author>Fisher, J. A.</author><author>Gowland, P. A.</author></authors></contributors><auth-address>Sir Peter Mansfield Magnetic Resonance, School of Physics and Astronomy, University of Nottingham, Nottingham, UK. nblockley@ucsd.edu</auth-address><titles><title>An improved method for acquiring cerebrovascular reactivity maps</title><secondary-title>Magn Reson Med</secondary-title><alt-title>Magnetic resonance in medicine</alt-title></titles><periodical><full-title>Magn Reson Med</full-title><abbr-1>Magnetic resonance in medicine</abbr-1></periodical><alt-periodical><full-title>Magn Reson Med</full-title><abbr-1>Magnetic resonance in medicine</abbr-1></alt-periodical><pages>1278-86</pages><volume>65</volume><number>5</number><keywords><keyword>Adult</keyword><keyword>Algorithms</keyword><keyword>Analysis of Variance</keyword><keyword>Brain Mapping/*methods</keyword><keyword>Carbon Dioxide/blood</keyword><keyword>Cerebrovascular Circulation/*physiology</keyword><keyword>Female</keyword><keyword>Fourier Analysis</keyword><keyword>Humans</keyword><keyword>Magnetic Resonance Imaging/instrumentation/*methods</keyword><keyword>Male</keyword><keyword>Respiration</keyword></keywords><dates><year>2011</year><pub-dates><date>May</date></pub-dates></dates><isbn>1522-2594 (Electronic)&#xD;0740-3194 (Linking)</isbn><accession-num>21500256</accession-num><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/21500256</url></related-urls></urls><electronic-resource-num>10.1002/mrm.22719</electronic-resource-num></record></Cite></EndNote>23 and fitting the signal response using a non-linear model. ADDIN EN.CITE 24 We chose to use linear regression with a variable CVR delay, since this method is relatively computationally efficient and there is good evidence for a tissue-dependent delay in the BOLD response to CO2. ADDIN EN.CITE 21 The BOLD signal was regressed with an intercept against ETCO2 and scan number (to account for linear signal drift). The CVR (units %/mmHg) is the regression coefficient corresponding to the ETCO2 regressor, with the latter shifted by the delay that minimizes the residual sum of squares, and is expressed as a percentage of the mean signal during the first 45 s of the paradigm. CVR and CVR delay were calculated in a voxel-wise manner to generate parameter maps using the mean signal for each ROI. CVR delay values were adjusted by +4 seconds to account for the time delay between exhalation and detection of CO2 concentration changes.
Image pre-processing: MR images were converted from DICOM to NIFTI format using SPM8 (Wellcome Department of Imaging Neuroscience, London, UK); BOLD dummy scans recorded prior to the start of the paradigm were discarded and the remaining volumes were spatially aligned to the mean volume using the two-pass procedure in SPM8. T1W images were co-registered to the T2W images using rigid-body registration and the transformation between the T2W and mean BOLD image spaces was determined (FSL FLIRT HYPERLINK \l "_ENREF_25" \o "Jenkinson, 2002 #41"  ADDIN EN.CITE <EndNote><Cite><Author>Jenkinson</Author><Year>2002</Year><RecNum>41</RecNum><DisplayText><style face="superscript">25</style></DisplayText><record><rec-number>41</rec-number><foreign-keys><key app="EN" db-id="v5sravvfipvw9tetrwo5xexpfdedvsdsvwtr" timestamp="1471356452">41</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Jenkinson, M.</author><author>Bannister, P.</author><author>Brady, M.</author><author>Smith, S.</author></authors></contributors><auth-address>Oxford Centre for Functional Magnetic Resonance Imaging of the Brain, John Radcliffe Hospital, Headington, United Kingdom.</auth-address><titles><title>Improved optimization for the robust and accurate linear registration and motion correction of brain images</title><secondary-title>Neuroimage</secondary-title></titles><periodical><full-title>Neuroimage</full-title><abbr-1>NeuroImage</abbr-1></periodical><pages>825-41</pages><volume>17</volume><number>2</number><keywords><keyword>Acoustic Stimulation</keyword><keyword>Algorithms</keyword><keyword>Brain/*physiology</keyword><keyword>Computer Simulation</keyword><keyword>Data Interpretation, Statistical</keyword><keyword>Fuzzy Logic</keyword><keyword>Humans</keyword><keyword>Image Interpretation, Computer-Assisted/*methods</keyword><keyword>Linear Models</keyword><keyword>Models, Neurological</keyword><keyword>Motion</keyword><keyword>Photic Stimulation</keyword><keyword>Reproducibility of Results</keyword></keywords><dates><year>2002</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>1053-8119 (Print)&#xD;1053-8119 (Linking)</isbn><accession-num>12377157</accession-num><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/12377157</url></related-urls></urls></record></Cite></EndNote>25).
Regions of interest (ROIs): The contrast-to-noise ratio of the BOLD signal for individual voxels is generally small, resulting in somewhat noisy parameter maps, particularly in the WM. HYPERLINK \l "_ENREF_23" \o "Blockley, 2011 #19"  ADDIN EN.CITE <EndNote><Cite><Author>Blockley</Author><Year>2011</Year><RecNum>19</RecNum><DisplayText><style face="superscript">23</style></DisplayText><record><rec-number>19</rec-number><foreign-keys><key app="EN" db-id="v5sravvfipvw9tetrwo5xexpfdedvsdsvwtr" timestamp="1463500022">19</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Blockley, N. P.</author><author>Driver, I. D.</author><author>Francis, S. T.</author><author>Fisher, J. A.</author><author>Gowland, P. A.</author></authors></contributors><auth-address>Sir Peter Mansfield Magnetic Resonance, School of Physics and Astronomy, University of Nottingham, Nottingham, UK. nblockley@ucsd.edu</auth-address><titles><title>An improved method for acquiring cerebrovascular reactivity maps</title><secondary-title>Magn Reson Med</secondary-title><alt-title>Magnetic resonance in medicine</alt-title></titles><periodical><full-title>Magn Reson Med</full-title><abbr-1>Magnetic resonance in medicine</abbr-1></periodical><alt-periodical><full-title>Magn Reson Med</full-title><abbr-1>Magnetic resonance in medicine</abbr-1></alt-periodical><pages>1278-86</pages><volume>65</volume><number>5</number><keywords><keyword>Adult</keyword><keyword>Algorithms</keyword><keyword>Analysis of Variance</keyword><keyword>Brain Mapping/*methods</keyword><keyword>Carbon Dioxide/blood</keyword><keyword>Cerebrovascular Circulation/*physiology</keyword><keyword>Female</keyword><keyword>Fourier Analysis</keyword><keyword>Humans</keyword><keyword>Magnetic Resonance Imaging/instrumentation/*methods</keyword><keyword>Male</keyword><keyword>Respiration</keyword></keywords><dates><year>2011</year><pub-dates><date>May</date></pub-dates></dates><isbn>1522-2594 (Electronic)&#xD;0740-3194 (Linking)</isbn><accession-num>21500256</accession-num><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/21500256</url></related-urls></urls><electronic-resource-num>10.1002/mrm.22719</electronic-resource-num></record></Cite></EndNote>23 Many studies have employed automatically generated tissue masks as ROIs to increase the contrast-to-noise ratio and improve the model fitting, though such an approach does not provide regional information and assumes a global CVR delay. We therefore selected an intermediate approach, using ROIs to reduce the influence of noise ADDIN EN.CITE 21 while retaining region- and tissue-specific information. Sixteen ROIs were chosen to sample WM and subcortical GM brain areas affected by SVD in addition to two cortical GM ROIs (Figure 2). First, an axial slice intersecting the basal ganglia was chosen and ROIs covering the caudate heads, thalamus and putamen were drawn. A second slice superior to the basal ganglia showing the lateral ventricles was chosen for WM (periventricular, frontal and posterior) and cortical GM (frontal and parietal lobe) ROIs. Finally, a slice superior to the lateral ventricles was selected and ROIs covering the centrum semiovale were drawn. For each slice, the ROIs were extended to cover the same regions or structures on a neighbouring slice to increase the signal-to-noise ratio (for frontal and posterior WM ROIs, three neighbouring slices were used). For patients, stroke lesions (as identified on the FLAIR image) were excluded from the ROIs. Finally, the ROIs were overlaid on the co-registered CVR maps; voxels covering midline hyperintensities on the CVR maps corresponding to blooming around the large veins and venous sinuses were excluded to reduce the influence of large vessels.
Statistical Analysis




Compliance, tolerability and symptoms
Among the 15 healthy volunteers (mean age 33.8 ± 9.5, range 22-50 years; 27% female), CVR scans were obtained in 13/15. Two subjects withdrew before data were collected (one tolerated the pre-scan CO2 test run but experienced claustrophobia shortly after entering the scanner and a second experienced anxiety during the pre-scan CO2 test run). Eleven of the 13 volunteers scanned agreed to be scanned on a second occasion (one had left the area, a second was excluded due to anxiety during the first visit); one of the repeat scans was halted due to sustained tachycardia that was likely caused by anxiety exacerbated by head cold symptoms (the subject had rated the first scan “very tolerable”). Two scans were interrupted due to scanner failure; at two of the visits the start time was not recorded, providing CVR but not CVR delay values. Most of the CVR scans (11/15 for visit 1, 9/12 for visit 2) were rated as either “tolerable” or “very tolerable” (Figure 3).
Volunteers had a range of previously described hypercapnia-related symptoms: respiratory symptoms (variously reported as shortness of breath, breathing resistance etc.; n=12 of 24 CVR scanning sessions initiated), anxiety (n=2), and temporary nausea, paraesthesia, confusion and blurred vision (n=1). Three participants had transient tachycardia apparent from physiological monitoring data. No symptoms were reported following 10 of the scans. One subject reported the 3-minute paradigm as more tolerable, while 2 subjects preferred the 1-minute paradigm and 1 subject chose a different paradigm at either visit; the remainder had no preference.
Among the 15 patients (mean age 66.4 ± 8.1, range 53-77 years; 20 % female), 14/15 completed CVR scanning, compared with 13/15 for the volunteers (one subject tolerated the hypercapnic challenge outside the scanner but was unable to tolerate MRI due to claustrophobia), all of whom rated the procedure as “tolerable” or “very tolerable” (Figure 3). Five patients reported no hypercapnia symptoms, while others reported respiratory symptoms (n=9), anxiety (n=1) and paraesthesia (n=1). Tolerability was similar among the 10 patients randomised to different CO2 concentrations: patients administered 4% CO2 rated the scans as very tolerable (n=2), tolerable (n=2) or intolerable (n=1; experienced claustrophobia as noted above), while those administered 6% CO2 rated the scans as either very tolerable (n=4) or tolerable (n=1). Since similar CVR values were observed (Figure 4e-f) with greater changes in ETCO2 for 6% versus 4% CO2 administration (12.8 ± 3.7 vs. 8.0 ± 1.0 mmHg, P < 0.01), the higher CO2 concentration was used for subsequent patient scans.
Patients had a range of radiological SVD features including lacunes (60%), cerebral microbleeds (6.7%), enlarged perivascular spaces (PVS; basal ganglia PVS scores: 1 (40%), 2 (40%), 3 (20%); centrum semiovale PVS scores: 0 (0%), 1 (33.3%), 2 (6.7%), 3 (46.7%), 4 (13.3%)) and white matter hyperintensities (perventricular Fazekas scores: 0 (6.7%), 1 (60%), 2 (33.3%); deep white matter Fazekas scores: 0 (13.3%), 1 (66.7%), 2 (20%)).

Comparison of Paradigms and Reproducibility in Healthy Volunteers
CVR and CVR delay measurements for each ROI are shown in Table 1 and Figure 4a-b. Average CVR was significantly greater for the 3-minute versus the 1-minute paradigm for all ROIs (0.041—0.313 vs. 0.021—0.251 %/mmHg respectively, p<0.05); the average CVR delay was similar in most GM ROIs, but was longer for the 3-minute paradigm in WM ROIs. Inter-visit coefficients of variation (CV; Table 2) were lower for the 3-minute paradigm in most ROIs (7.9–15.4 % vs. 11.7–70.2 % respectively for CVR in GM). Large or negative variance estimates were found in some ROIs for the 1-minute paradigm; inspection of the Bland-Altman plots (Supplementary Figures 1-4) and individual model fits showed these data to be affected by outliers caused by the periodicity of the 1-minute paradigm; as illustrated in Supplementary Figure 5, the algorithm fits some noisy data by reversing the sign of the fitted CVR while increasing the CVR delay by 60 s. This effect was not seen for the 3-minute paradigm due to the lower frequency of the stimulus.
Regional CVR in Healthy Volunteers and Patients




Several cerebrovascular vasodilatory stimuli and paradigms have been presented in the literature but rarely tested in our patient population. Our first aim was therefore to select a suitable stimulus for studies of cerebral small vessel disease and minor stroke. A range of methods have been proposed, including simple respiratory challenges such as breath-holding and hyperventilation, pharmacologic stimuli such as acetazolamide, inspired gas challenges and automated systems for targeting precise changes in end-tidal gas concentration. We selected a hypercapnic challenge because CO2 is endogenous, simple to administer and measure using widely available equipment, and safe to inhale at low concentrations. A fixed-inspired CO2 challenge was chosen as a compromise between experimental precision and ease of implementation for use in multicentre clinical studies: unlike an acetazolamide injection, a CO2 stimulus is easily administered and quickly reversed; hyperventilation and breath-hold challenges require less equipment but rely on a higher degree of participant cooperation, and with breath holding it is difficult to monitor the participant’s physiological parameters non-invasively. The benefits and drawbacks of different CVR challenges, ,  and other practical aspects of CVR measurement in clinical research, HYPERLINK \l "_ENREF_27" \o "Moreton, 2016 #39"  ADDIN EN.CITE <EndNote><Cite><Author>Moreton</Author><Year>2016</Year><RecNum>39</RecNum><DisplayText><style face="superscript">27</style></DisplayText><record><rec-number>39</rec-number><foreign-keys><key app="EN" db-id="v5sravvfipvw9tetrwo5xexpfdedvsdsvwtr" timestamp="1470841574">39</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Moreton, F. C.</author><author>Dani, K. A.</author><author>Goutcher, C.</author><author>O&apos;Hare, K.</author><author>Muir, K. W.</author></authors></contributors><auth-address>Department of Neurology, Institute of Neurosciences and Psychology, University of Glasgow, Queen Elizabeth University Hospital Glasgow, 1345 Govan Road, Glasgow G51 4TF, United Kingdom.&#xD;Department of Neuroanaesthesia, Institute of Neurological Sciences, Queen Elizabeth University Hospital Glasgow, 1345 Govan Road, Glasgow G51 4TF, United Kingdom.</auth-address><titles><title>Respiratory challenge MRI: Practical aspects</title><secondary-title>Neuroimage Clin</secondary-title></titles><periodical><full-title>Neuroimage Clin</full-title></periodical><pages>667-77</pages><volume>11</volume><keywords><keyword>Cerebral blood flow</keyword><keyword>Cerebrovascular reactivity</keyword><keyword>Magnetic resonance imaging</keyword><keyword>Respiratory challenge</keyword><keyword>Review</keyword></keywords><dates><year>2016</year></dates><isbn>2213-1582 (Electronic)&#xD;2213-1582 (Linking)</isbn><accession-num>27330967</accession-num><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/27330967</url></related-urls></urls><custom2>PMC4901170</custom2><electronic-resource-num>10.1016/j.nicl.2016.05.003</electronic-resource-num></record></Cite></EndNote>27 have been discussed in detail elsewhere. We chose to use a 6% CO2 concentration in medical air since we measured similar CVR values and tolerability with greater ETCO2 and signal changes with this gas mixture in a randomised comparison with 4% CO2. Carbogen (CO2 and O2 with no nitrogen) gas mixtures have also been used for measuring CVR but the effects on the BOLD signal via changes in CBF and other mechanisms are more complex. ADDIN EN.CITE 28 The experiments performed here could also be performed using a computerised system for prospective targeting of ETCO2 values, subject to sufficient patient cooperation, availability of specialised equipment and provided a calibration step is performed before CVR scanning; such an approach should result in a more reproducible stimulus with better correspondence between ETCO2 and arterial PaCO2.29
Comparing two previously published hypercapnia paradigms, we found the paradigm based on 3-minute CO2 spells to be more reliable than a 1-minute paradigm for measuring CVR and the CVR delay. This is partly because more signal is collected during the 3-minute paradigm (12 minutes versus 7 minutes total duration). Another factor is the longer repetition period of the 3-minute paradigm, which reduces the likelihood of selecting the “wrong” minima as illustrated in Supplementary Figure 5. Such errors were observed in a small number of cases only due to the use of pre-scan ETCO2 data, which negates the periodicity of the paradigm; such errors could be further suppressed by further constraining the permitted delay values, but this would potentially bias the results, particularly in regions, voxels or patients with slow CVR response (the group of greatest interest) and appropriate arbitrary limits would be difficult to determine a-priori without further knowledge of human cerebrovascular biology. We also found that CVR and the CVR delay were on average greater for the 3-minute paradigm, with the difference more pronounced in WM ROIs. This observation suggests that the linear regression model is an incomplete description of the BOLD response to changes in ETCO2. Improved fitting will likely result from convolving the ETCO2 regressor with an impulse response function ADDIN EN.CITE 21 or by permitting multiple (e.g. fast and slow) components to the response in any given tissue. However, the ideal approach is yet to be determined and the inclusion of additional fitting parameters would increase the computational burden and likely reduce the precision of other parameters. Further investigation is required to determine the optimal approach and care should be taken when comparing CVR values between studies. In general, data were more reproducible for GM than WM ROIs, which is expected due to the greater CBF in GM. The tolerability was similar for the two paradigms tested. Healthy volunteers had a similar rate of hypercapnia-related symptoms to patients but, on average, found the CVR procedure less tolerable compared with patients; this may be due to the administration of two CVR paradigms per session in volunteers, or due to healthy volunteers being less accustomed than patients to medical procedures. Encouragingly, all patients who underwent CVR scanning described the experience as either “tolerable” or “very tolerable”. In an analysis of 434 CVR scans across multiple patient groups, Spano et al. also reported a high success rate for examinations using a prospective ETCO2 targeting approach, with CVR maps generated for 83.9% of scans. ADDIN EN.CITE 30
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The voxel-wise BOLD signal response to hypercapnia typically has low contrast-to-noise ratio, particularly in the WM, resulting in noisy parameter maps. As a result, several previous studies have used whole-brain tissue masks, but this precludes region-specific information needed for studies of SVD, which primarily affects periventricular WM, deep WM and subcortical GM. We therefore selected an intermediate approach, averaging signal over ROIs to reduce parameter uncertainty while retaining region-specific information. This approach also permits manual exclusion of the large draining veins and sinuses, which have a significant influence on the signal in surrounding voxels due to the “blooming” effect. Despite this approach, reproducibility was lower in ROIs with low CVR; use of higher field MRI (e.g. 3T) should in principle permit increased reproducibility in these regions. 
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BOLD CVR was on average greater in healthy volunteers than in patients for most ROIs. Since the primary purpose of this work was to develop and assess protocols, the groups were not matched for age or vascular risk factors. However, the difference is consistent with the expected reduction in vasoreactivity both with ageing ADDIN EN.CITE ,  (patients were older than the healthy volunteers) and cerebrovascular disease. ADDIN EN.CITE ,  More surprisingly, the CVR delay was shorter for patients in most ROIs. Thomas et al. also reported a longer CVR delay in young versus older participants, though neither group comprised patients. 
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Table 1: Mean CVR and CVR Delay measurements in healthy volunteers and patients. Healthy volunteer measurements were first averaged over both scans. * indicates a significant difference between 1-minute and 3-minute paradigms, while † indicates a significant difference between patients and healthy volunteers (3-minute paradigm; p < 0.05).

region	CVR (%/mmHg)	CVR Delay (s)
	healthy volunteers	patients	healthy volunteers	patients
	1-minute	3-minute	3-minute	1-minute	3-minute	3-minute
FCGM	0.193 (0.053)	0.230* (0.056)	0.110† (0.042)	9.9 (2.6)	11.9* (3.0)	10.0 (6.4)
PCGM	0.251 (0.053)	0.313* (0.064)	0.234† (0.079)	12.7 (3.0)	14.5* (3.5)	14.3 (6.2)
LCH	0.147 (0.063)	0.172* (0.050)	0.124† (0.064)	11.9 (8.0)	11.0 (2.9)	1.3† (11.7)
RCH	0.142 (0.060)	0.174* (0.050)	0.120† (0.055)	11.2 (8.4)	10.5 (2.7)	4.1 (13.3)
LP	0.151 (0.067)	0.188* (0.072)	0.139 (0.046)	11.4 (8.0)	10.0 (2.9)	11.4 (4.3)
RP	0.164 (0.082)	0.207* (0.097)	0.144 (0.054)	10.8 (8.0)	9.7 (2.9)	10.7 (5.7)
LT	0.197 (0.045)	0.250* (0.061)	0.163† (0.063)	10.3 (3.1)	13.3* (3.0)	11.3 (5.3)
RT	0.208 (0.060)	0.270* (0.116)	0.158† (0.058)	10.3 (3.2)	12.9* (3.9)	11.4 (5.1)
LCS	0.021 (0.014)	0.041* (0.015)	0.040 (0.024)	28.0 (18.0)	47.9* (19.6)	26.2† (20.2)
RCS	0.022 (0.016)	0.045* (0.013)	0.038 (0.013)	30.8 (18.8)	43.3* (23.0)	43.9 (23.9)
LPVWM	0.076 (0.046)	0.124* (0.055)	0.090 (0.042)	20.3 (8.1)	31.1* (10.1)	21.8† (9.0)
RPVWM	0.063 (0.020)	0.101* (0.031)	0.092 (0.047)	19.9 (6.1)	34.0* (8.9)	24.1† (8.1)
LFWM	0.028 (0.023)	0.055* (0.032)	0.038 (0.016)	27.7 (17.4)	34.5 (28.4)	28.9 (36.3)
RFWM	0.024 (0.023)	0.053* (0.015)	0.035† (0.021)	32.2 (26.2)	41.6 (20.5)	16.2† (20.5)
LPWM	0.026 (0.022)	0.047* (0.014)	0.060 (0.025)	24.3 (17.0)	47.8* (18.6)	41.8 (21.7)
RPWM	0.031 (0.028)	0.061* (0.019)	0.063 (0.020)	29.7 (23.3)	46.0* (18.7)	41.6 (24.0)






Table 2: Coefficients of variation (%) resulting from variance component analysis of healthy volunteer data for both CO2 paradigms. The ANOVA procedure yielded negative variance component estimates in some ROIs for the 1-minute paradigm; these values, which may be caused by outliers as described in the text, are not shown and are indicated by “- “.

























Figures and figure legends












Figure 4: Mean (a) CVR and (b) CVR delay values in healthy volunteers for the 1-minute and 3-minute CO2 paradigms, averaged first over visits and secondly over subjects. (c-d) compare mean (c) CVR and (d) CVR delay values for healthy volunteers and patients, obtained using the 3-minute gas paradigm. (e-f) compare mean (e) CVR and (f) CVR delay for patients scanned using 4% (n=4) and 6% (n=10) CO2 gas mixtures. “*” indicates a significant difference (p < 0.05) between paradigms, between patients and volunteers, or between CO2 concentrations; error bars indicate the standard deviation after averaging over visits (part (a) only).
























Supplementary Figure 5: BOLD MRI signal (dotted line) and model fit (solid line) for the left putamen ROI of a healthy volunteer using the 1-minute CO2 paradigm (LHS) with graphs showing the sum-of-squared residuals as a function of the time shift. At visit 1 (A), a positive CVR is fitted with a time shift of 5 s, while at visit 2 (B), a likely-erroneous negative CVR is fitted with a time shift of 62 s. This effect is not observed with the 3-minute CO2 paradigm due to the longer oscillation period.
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